Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the gene delivery technologies market right now?
The market size of gene delivery technologies has witnessed swift development in the previous few years. The market, which was valued at $3.79 billion in 2024, is projected to rise to $4.3 billion in 2025, marking a compound annual growth rate (CAGR) of 13.6%. The significant growth during the historic period can be traced back to multiple factors, including improved comprehension of genetic diseases, progress in cell therapy, the emergence of nanotechnology, the expansion of gene therapy trials, and an upsurge in research funding.
How fast Is the gene delivery technologies market expected to grow, and what’s its future value?
The market size of gene delivery technologies is projected to experience a swift rise in the coming years, with a forecasted value of “$7.44 billion by 2029, indicating a compound annual growth rate (CAGR) of 14.7%. This impressive spike throughout the predicted period owes its momentum to the advancement of precision medicine, the refinement of the regulatory infrastructure, accelerated gene therapy, and the widening scope of non-viral delivery systems. The period will bear witness to significant trends, such as the application in rare diseases, increase in clinical trials, the evolution of targeted drug delivery, the enlargement of cell therapy, and the progression of gene editing tools.
Get your gene delivery technologies market report here!
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
What are the leading drivers of growth in the gene delivery technologies market?
The gene delivery technologies market is predicted to expand due to the rising number of cell and gene therapies. These therapies are essentially medical interventions that modify a patient’s cellular and genetic composition to treat or alleviate diseases. The surge in cell and gene therapies is primarily attributed to developments in gene editing technologies, which are vital in creating and marketing these therapies. For example, the Association of the British Pharmaceutical Industry, a UK-based trade organization, reported in August 2024 that the UK typically approves an average of two ATMPs each year. However, this number is anticipated to grow to 10-15 approvals annually by 2030. Consequently, the number of patients receiving these therapies in the UK may rise from 2,500 in 2021 to potentially 10,000 per annum by 2028. Hence, the increase in cell and gene therapies propels the growth of the gene delivery technologies market.
What are the key segments defining the gene delivery technologies market?
The gene delivery technologies market covered in this report is segmented –
1) By Mode: Biological, Chemical, Physical
2) By Method: Ex Vivo, In Vivo, In Vitro
3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research
Subsegments:
1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles
2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents
3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp
Who are the key players steering the development of the gene delivery technologies market?
Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG
What emerging trends are influencing the growth of the gene delivery technologies market?
The rise of technological innovation is a significant trend becoming prominent in the gene delivery technologies market. Key players in the market are focusing on the development of technologically superior products to fortify their market position. For instance, in February 2023, Aera Therapeutics, a biotech firm based in the USA, introduced Aera’s Platform delivery technology aimed at harnessing the power of genetic medicines. Their PNP technology enables accurate targeting of RNA molecules involved in disease pathways. This innovation permits targeted gene editing within a patient’s cells, thereby opening avenues for individualized gene therapies.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10706
Which regions are most influential in expanding the gene delivery technologies market?
North America was the largest region in the gene delivery technologies market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Food Encapsulation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-encapsulation-global-market-report
Multivitamin Capsules And Tablets Global Market Report 2024
Vitamin and Minerals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vitamin-and-mineral-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
